Achieve Clinical, Financial, and Administrative Excellence

In supporting healthcare providers, Revenue To Go improves your practice development strategy, enhances your operating efficiencies, and jumpstarts your earnings growth.

Firstly, we help you master the essentials:

• Billing and collections
• Revenue cycle management
• Clinical management, practice management, and service portfolio management
• Patient registries for real-time proof of value (POV)
• Patient-centered innovation (PCI)

We roll up our sleeves to:

• improve your coding, billing, claims management, appeals, and collections;
• manage third-party payer (TPP) and out-of-pocket (OOP) receivables;
• reduce days sales outstanding (DSO, the time between service delivery and receipt of payment);
• increase your revenue under fee-for-service (FFS) and value-based payment (VBP) models; and
• ensure you become a clinical leader, volume leader, and value leader in your region.

Second, we ensure you participate in—and secure incremental revenue, earnings growth, and competitiveness from—breakthroughs, best practices, and benchmarks originating both domestically and abroad.

We monitor all three sectors that have the potential to improve your performance, outcomes, and impacts:

• Global advances in health and medicine
• Global advances in education
• Global advances in social services and social determinants of health (SDOH)

This positions us to identify, evaluate, and get you access to groundbreaking and disruptive innovations sure to become The Next Big Thing.

We do the hard work of ensuring each disruptive innovation has been carefully evaluated using the Academy of Managed Care Pharmacy (AMCP), Institute for Clinical and Economic Review (ICER), and other frameworks to achieve proof of value (POV).

We will:

• Consider key stakeholder perspectives from across the healthcare continuum, including patients, healthcare professionals, healthcare provider organizations, third-party administrators, third-party payers, healthcare policymakers, healthcare researchers, medical product manufacturers, and health information technology companies.
• Use validated and publicly available analytic methodologies and economic models (e.g., patient activation measures [PAM, activities of daily living [ADL], and quality of life [QOL] assessment from PROQOLID and/or cost-minimization, cost-benefit, cost-effectiveness, and cost-utility models described in HealthEconomics.com).
• Incorporate scientifically valid evidence (aka real-world evidence [RWE]) from multiple sources (e.g., real-world data [RWD] such as post-market surveillance data, clinical outcome assessments [COAs], and patient-reported outcomes [PRO]).
• Create value calculators, value frameworks, and plain language summaries (PLS) of value studies that enable clinical, financial, and administrative decision-makers to make value-based policy and value-based therapeutic decisions by applying their own assumptions and better-interpret study findings.
• Evaluate the knowledge, skills, and impartiality of researchers (e.g., by conducting background checks, verifying credentials, and reviewing Sunshine Act data on monies received from industry).
• Update value frameworks based on state-of-the-art evaluation and cross-channel communication techniques.

All of this ensures you remain at the forefront of the industry in clinical, financial, and administrative performance to protect and enhance your practice, operating efficiencies, and earnings growth.